Table of Contents
- Complete Table of Contents
- Training Link
- Protocol Names and changes
Sec. 1: General Treatment
- Section 1- Table of Contents
- 1.1 General Pre Hospital Care
- 1.2 Abdominal Pain (Non Traumatic)
- 1.3 Nausea & Vomiting
- 1.4 Syncope
- 1.5 Shock
- 1.6 Anaphylaxis Allergic Reaction
- 1.7 Adrenal Crisis
- 1.8 Behavioral Health Emergencies
- 1.8S-Pre-Hospital ED Coordination and Management of Psychiatric Patients
- 1.9 Opioid Overdose Treatment and Prevention
- 1.10 Foreign Body Airway Obstruction
Sec. 2: Trauma & Environmental Emergencies
- Section 2- Table of Contents
- 2.1 Adult Pediatric Trauma Triage
- 2.2 General Trauma
- 2.3 Burns
- 2.4 General Crush Injury
- 2.5 Soft Tissue and Orthopedic Injuries
- 2.6 Spinal Injury Assessment
- 2.7 Traumatic Arrest
- 2.8 Drowning Submersion Injury
- 2.9 Poisoning Overdose Environmental Exposure
- 2.10 Heat Emergencies
- 2.11 Hypothermia Frostbite
- 2.12 Head Injury Moderate and Severe TBI
- 2.13 Bleeding Control (BCON)
- 2.14 Hemorrhagic Shock
- 2.15 Sexual Assault
Sec. 3: Adult Treatment
Sec. 4: Obstetrics and Pediatrics
- Section 4- Table of Contents
- 4.1 Pediatric Medication Emergency Dosing and Intervention Cards
- 4.2 Childbirth and Related Obstetrical Emergencies
- 4.3 Newborn and Neonatal Assessment and Resuscitation
- 4.4 Pediatric Altered Mental Status
- 4.5 Pediatric Respiratory Distress, Failure or Arrest
- 4.6 Pediatric Fever
- 4.7 Pediatric Seizures
- 4.8 Safe Transportation of Children in Ambulances
- 4.9 Pediatric Crashing Patient Impending Arrest
Sec. 5: Adult Cardiac
Sec. 7: Procedures
- Section 7- Table of Contents
- 7.1 12- Lead ECG
- 7.2 Child Abuse and Neglect
- 7.3 Crime Scene Management
- 7.3(s) Medical Response to a Crime Scene
- 7.4 Vulnerable Adult Abuse, Neglect, or Exploitation
- 7.5 CPAP
- 7.6 Dead on Scene and Termination of Resuscitation
- 7.6(S) Dead on Scene Supplement
- 7.7 Do Not Resuscitate
- 7.8 Electrical Therapy
- 7.8 (S) Double Sequential Defibrillation
- 7.9 Airway Management
- 7.10 Helmet Removal
- 7.11 Impedance Threshold Device (ITD)
- 7.12 Oxygen Admininstration
- 7.13 Pain Management
- 7.13(S) Pain Management Supplement
- 7.14 Patient Assessment
- 7.15 Documentation and Patient Care Records
- 7.15 (S) EPCR PCR and Transfer of Care
- 7.16 Patient Restraint
- 7.17 Patient Procedural Sedation
- 7.18 Pleural Decompression
- 7.19 Refusal of Care; Adult and Minor
- 7.20 Spinal Precautions
- 7.21 Blood Glucose Level Testing
- 7.22. Tourniquet Application
- 7.23 Vascular Access & IV Fluid Therapy
- 7.24 End Tidal Carbon Dioxide Monitoring
- 7.25 MI-POST
- 7.25(S) Michigan Physician Order for Scope of Treatment
- 7.26 Not Adopted
- 7.27 Transport of Adult Ventilator Dependent Patient
- 7.28 Left Ventricular Assist Device (LVAD)
- 7.29 Mechanical Chest Compression Device
- 7.30 Active Compression Decompression Device
Sec. 8: System
- Section 8- Table of Contents
- 8.1 Downgrade of Response
- 8.2 Patient Prioritization and Use of Lights and Sirens
- 8.3 Transport Destination and Diversion
- 8.3(S) Emergency Facilities Limitation Policy
- 8.4 OB High Risk Delivery Transport Guidelines
- 8.5 ALS and LALS Intercept:Transfer of Care
- 8.6 Dispatch
- 8.6(S) Emergency Medical Dispatch Provider Criteria for Endorsement
- 8.6(S2) Mike Echo Unit_Treatment and Transport Coordination
- 8.7 ALS to BLS Transfer of Care
- 8.8 Air Ambulance Personnel Scope of Practice
- 8.9 Helicopter Utilization
- 8.9(S) TransportDestination Map guide
- 8.10 Infection Control and Communicable Disease
- 8.11 Immunization & Testing
- 8.12 Communications Failure
- 8.12(S) Radio Incident Failure Report
- 8.13 Electronic Records & EMS Information System
- 8.14 Protected Health Information (PHI)
- 8.15 Interfacility Patient Transfers
- 8.15(S1) Interfacility Pt Transfers and CC Pt Transports of Adult Non-Criical Vent Dependent Pt
- 8.15(S2) Critical Care Patient Transport Curriculum
- 8.15(S3) HHFNC Administration Adult and Pediatric
- 8.15(S4) NTG and Heaparin Drip Interfacility
- 8.16 Licensure Level Requirement of Attendant during Transport
- 8.16 (S) Life Support Unit Personnel Staffing: Alternate Staffing
- 8.17 Medical Control Privileges
- 8.17(S1) Pre-Hospital Equipment Responsibility
- 8.17(S2) Additiional Equipment and Training
- 8.18 Responsibilities of the Participants in the MCA System
- 8.19 On Scene Physician Interaction
- 8.19(S) Scene and Patient Management Policy
- 8.20 Protocol Deviation
- 8.21 Violent: Chemical: Hazardous Scene
- 8.22 Medical Examiner Notification and Body Disposition
- 8.23 Safe Delivery of Newborns
- 8.24 Complaint Investigation & Resolution
- 8.25 Disciplinary Action Appeal
- 8.26 EMS Provider Criminal Charges and Convictions
- 8.27 Quality Improvement Program
- 8.27(S) Integrated Agency System PSRO QI Plan
- 8.28 Not Adopted
- 8.29 General Operations
- 8.29(S1) Access to HEMS Communication System
- 8.29(S2) EMS Communications Interoperability
- 8.29(S3) Transfer of Care
- 8.30 Hospice Patient Coordination of Services
- 8.31 Alternative EMS Response Team
- 8.31 (S) Special Event Medication Drug Box
Sec. 9: Medications
- Section 9- Table of Contents
- 9.1 Medication Administration
- 9.2 Medication Substitution
- 9.3 Medication Shortage
- 9.4 Personal Metered Dose Inhaler Use
- 9.5 IV Ancillary Supply Exchange
- 9.6 SE MICHIGAN MEDICATION EXCHANGE AND REPLACEMENT PROCEDURE_V37 November 2023-2
- 9.6(S1) MFR:BLS Medications Kit Contents and Exchange Procedure
- 9.6(S2) BLS Nebulized Bronchodilator Kit Contents and Exchange Procedure
- 9.7 Not Adopted
- 9.8 Naloxone Leave Behind Medication Kit Contents and Distribution Procedure
- 9.9 Medications General
- 9.10 Acetaminophen
- 9.11 Adenosine
- 9.12 Albuterol
- 9.13 Amiodarone
- 9.14 Aspirin
- 9.15 Atropine
- 9.16 Calcium Chloride
- 9.17 Cefazolin
- 9.18 Ceftriaxone
- 9.19 Dextrose
- 9.20 Diazepam
- 9.21 Diltiazem
- 9.22 Diphenhydramine
- 9.23 Epinephrine
- 9.24 Fentanyl
- 9.25 Glucagon
- 9.26 Hydroxocobalamin
- 9.27 Ibuprofen
- 9.28 Ipratropium Bromide
- 9.29 Ketamine
- 9.30 Ketorolac
- 9.31 Lidocaine
- 9.32 Magnesium Sulfate
- 9.33 Methylprednisolone
- 9.34 Midazolam
- 9.35 Morphine
- 9.36 Naloxone
- 9.37 Nitroglycerin
- 9.38 Ondansetron
- 9.39 Pralidoxime
- 9.40 Prednisone
- 9.41 Sodium Bicarbonate
- 9.42 Racepinephrine
- 9.43 Tetracaine
- 9.44 Tranexamic Acid
- 9.45 Verapamil
- 9.46 Cardizem
- 9.47 Acetylcysteine
- 9.48 Magnesium Sulfate (Interfacility Transfer)
- 9.49 Tissue Plasminogen Activator
- 9.50 Octreotide
- 9.51 Furosemide
- 9.52 Levetiracetam
- 9.53 Blood Products
- 9.54 Glycoprotein Receptor Antagonist
- 9.55 2-Pam Chloride:Duodote
- 9.56 Dopamine
- 9.57 Hydromorphone
- 9.58 Lorazepam
Sec. 10: Special Operations
- Section 10- Table of Contents
- 10.1 General CBRNE Indetification of Agents
- 10.2 Chemical Exposure
- 10.3 Nerve Agent: Organophosphate Pesticide Exposure Treatment
- 10.4 CHEMPACK: MEDDRUN
- 10.5 Cyanide Exposure
- 10.6 Mass Casualty Incidents
- 10.6(S) Multiple Patients Incidents- Quick Guide
- 10.7 Pre-Hospital (EMS) MCA Mutual Aid during Disaster
- 10.7(S) Wayne:Monroe County Coordination of Services and Transportation Agreement
- 10.8 Hazard Contaminated Patient
- 10.9 Suspected Pandemic
- 10.10 SPRN Transport and Destination Guidelines
- 10.11 SPRN Patient Containment Algorithm
- 10.12 SPRN Transport Supplies
- 10.13 SPRN Transport Procedure
- 10.14 SPRN Patient Care during Transport of Suspected Highly Infectious Agent
- 10.15 SPRN Ambulance Cleaning and Disinfection
- 10.16 SPRN Medical Isolation Transport Device
- 10.17 SPRN Team Selection Procedure
- 10.18 SPRN Death during Transport
- 10.19 Hazardous Material Procedure
- 10.20 Hazardous Materials- Medical Treatment
- 10.21 Radiation Emergency Procedure
- 10.22 Incidents Involving Use of Suspicious Powders